After the Duchess of Sussex announced her American Riviera Orchard rebrand, she once again is facing accusations of ...

Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...

February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...

Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies for use in hard-to-treat cancers by targeting a new class of untapped ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Vermilion Cliffs Ventures founder Ashley Smith. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

The physics PhD served as a program officer and fellow at the Bill & Melinda Gates Foundation before spending a year as the chief scientific officer at a venture-backed startup called TL Biolabs.

PARIS (Reuters) - Carmaker Stellantis, brands of which include Fiat, Peugeot and Vauxhall, said it had agreed to buy full control of its joint venture with Belgium's Punch Powertrain, strengthening ...

RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly ...

Venture Global's IPO, initially valued at $110 billion, was reset to $60 billion, offering 70 million shares at $25 each, making it attractive for long-term-focused investors. VG's innovative ...